JP4846581B2 - ベンゾトロポロン誘導体および炎症反応の緩和 - Google Patents

ベンゾトロポロン誘導体および炎症反応の緩和 Download PDF

Info

Publication number
JP4846581B2
JP4846581B2 JP2006524941A JP2006524941A JP4846581B2 JP 4846581 B2 JP4846581 B2 JP 4846581B2 JP 2006524941 A JP2006524941 A JP 2006524941A JP 2006524941 A JP2006524941 A JP 2006524941A JP 4846581 B2 JP4846581 B2 JP 4846581B2
Authority
JP
Japan
Prior art keywords
compound
benzotropolone
compounds
acetone
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006524941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504168A5 (enExample
JP2007504168A (ja
Inventor
ホー，チー−タン
ガイ，ジーサ
サン，シェンミン
ジョー，ジン−ウー
ファン，モウ−トゥアン
ローゼン，ロバート，ティー．
ドゥーシェンコフ，スラビック
Original Assignee
ウエルジェン，インコーポレーテッド
ラトガーズ，ザ ステイト ユニバーシティー オブ ニュージャージー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウエルジェン，インコーポレーテッド, ラトガーズ，ザ ステイト ユニバーシティー オブ ニュージャージー filed Critical ウエルジェン，インコーポレーテッド
Publication of JP2007504168A publication Critical patent/JP2007504168A/ja
Publication of JP2007504168A5 publication Critical patent/JP2007504168A5/ja
Application granted granted Critical
Publication of JP4846581B2 publication Critical patent/JP4846581B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/38—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006524941A 2003-08-29 2004-08-30 ベンゾトロポロン誘導体および炎症反応の緩和 Expired - Fee Related JP4846581B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/652,813 US7087790B2 (en) 2003-08-29 2003-08-29 Benzotropolone derivatives and modulation of inflammatory response
US10/652,813 2003-08-29
PCT/US2004/028164 WO2005021479A1 (en) 2003-08-29 2004-08-30 Benzotropolone derivatives and modulation of inflammatory response

Publications (3)

Publication Number Publication Date
JP2007504168A JP2007504168A (ja) 2007-03-01
JP2007504168A5 JP2007504168A5 (enExample) 2007-10-11
JP4846581B2 true JP4846581B2 (ja) 2011-12-28

Family

ID=34217746

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524941A Expired - Fee Related JP4846581B2 (ja) 2003-08-29 2004-08-30 ベンゾトロポロン誘導体および炎症反応の緩和

Country Status (6)

Country Link
US (2) US7087790B2 (enExample)
EP (1) EP1663931B1 (enExample)
JP (1) JP4846581B2 (enExample)
CN (1) CN1852881B (enExample)
CA (1) CA2536842C (enExample)
WO (1) WO2005021479A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087790B2 (en) * 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response
CA2608651A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
WO2008019985A1 (en) * 2006-08-14 2008-02-21 Unilever Plc Method of purifying theaflavins
EP3238544A1 (en) 2008-03-21 2017-11-01 Rutgers, The State University of New Jersey Use of tea-derived, theaflavin enriched extract to increase exercise performance and reduce exercise recovery time
WO2009156324A2 (en) * 2008-06-25 2009-12-30 Basf Se Use of benzotropolone derivatives as uv absorbers and antioxidants and their use in sunscreens and/or cosmetic compositions
RU2396244C1 (ru) * 2008-12-23 2010-08-10 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) Способ получения пурпурогаллина
ES2643463T3 (es) 2009-05-21 2017-11-23 Suntory Holdings Limited Agente antiobesidad que comprende un compuesto que contiene un anillo de benzotropolona
BR112012007685B1 (pt) * 2009-10-06 2024-03-05 Basf Se Uso de derivados de benzotropolona
US8282970B2 (en) * 2009-10-07 2012-10-09 Jiahgsu Dehe Bio-Tech Co., Ltd Theaflavin compositions, related processes and methods of use
US20110082198A1 (en) * 2009-10-07 2011-04-07 Jiangsu Dehe Bio-Tech Co., Ltd. Theaflavin compositions, production, and methods to control physiological disorders in mammals
JP5424424B2 (ja) * 2011-10-03 2014-02-26 国立大学法人 鹿児島大学 抗炎症剤または抗炎症作用を有する飲食品
EP2879669A4 (en) * 2012-07-29 2016-04-13 Univ Colorado Regents ANTAGONISTS OF THE TOLL LIKE RECEPTOR 1/2 COMPLEX
JP2014148530A (ja) * 2014-04-21 2014-08-21 Amazonia Fitomedicamentos Ltda ラノスタ−８，２４−ジエン−３−オールの薬学的使用
JP6628970B2 (ja) * 2015-03-09 2020-01-15 サントリーホールディングス株式会社 ベンゾトロポロン環含有化合物を定量する方法
EP3370523A4 (en) 2015-11-04 2019-12-18 The Penn State Research Foundation CONNECTIONS, COMPOSITIONS AND METHOD FOR COLORING EDIBLE MATERIALS
WO2018096088A1 (en) * 2016-11-24 2018-05-31 Universiteit Antwerpen Halogenated benzotropolones as atg4b inhibitors
WO2020018474A2 (en) 2018-07-16 2020-01-23 Ziegler Gregory Ray Compounds, compositions, and methods for coloring edible materials
CN114869878B (zh) * 2022-04-08 2024-02-23 南通大学 表儿茶素没食子酸酯在制备治疗高原脑水肿药物中的应用
JP2024056384A (ja) * 2022-10-11 2024-04-23 ライオン・スペシャリティ・ケミカルズ株式会社 炎症性因子産生抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812266A (en) * 1972-01-31 1974-05-21 Lipton T Inc Green tea conversion using tannase and natural tea enzymes
TW381092B (en) 1995-07-07 2000-02-01 Otsuka Pharma Co Ltd Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
US6469053B1 (en) 1996-04-02 2002-10-22 Mars Incorporated Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response
US5861415A (en) 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
ATE207068T1 (de) 1997-07-15 2001-11-15 Unilever Nv Verbesserungen bezüglich auf theaflavin erzeugung
GB9902777D0 (en) * 1999-02-08 1999-03-31 Unilever Plc Cold water infusing leaf tea
CA2383224C (en) 1999-09-21 2010-12-07 Geetha Ghai Extracts of orange peel for prevention and treatment of cancer
US6348224B1 (en) 2000-03-16 2002-02-19 Lipton, Division Of Conopco, Inc. Black tea manufacture
AU2001261004B2 (en) 2000-03-22 2006-07-13 Mars, Incorporated The use of cocoa procyanidins combined with acetylsalicyclic acid as an anti-platelet therapy
JP3694733B2 (ja) 2000-06-29 2005-09-14 独立行政法人農業・生物系特定産業技術研究機構 抗アレルギー剤
US7087790B2 (en) * 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response

Also Published As

Publication number Publication date
US20050049284A1 (en) 2005-03-03
CA2536842A1 (en) 2005-03-10
WO2005021479A1 (en) 2005-03-10
US20060241154A1 (en) 2006-10-26
US7087790B2 (en) 2006-08-08
US7288680B2 (en) 2007-10-30
EP1663931A4 (en) 2006-10-18
CN1852881B (zh) 2010-09-29
JP2007504168A (ja) 2007-03-01
EP1663931B1 (en) 2013-04-10
CA2536842C (en) 2014-10-07
CN1852881A (zh) 2006-10-25
EP1663931A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
EP1663931B1 (en) Benzotropolone derivatives and modulation of inflammatory response
CN101133043B (zh) 原花色素低聚物的制造方法
KR100257448B1 (ko) 항암, 기관분화유도, 암세포전이 혈관형성억제, 항산화 및 숙취해소 작용을 하는 옻나무 추출물, 이의 제조방법 및 이를 포함하는 조성물
US20110195138A1 (en) Anti-inflammatory cranberry flavonol extract preparations
WO1999012541A1 (en) Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
US20110028742A1 (en) Sulfur-containing proanthocyanidin oligomer composition and production method thereof
EP2633886A1 (en) Compounds and mixtures influencing inflammatory states
US20090048332A1 (en) Natural Novel Antioxidants
CA2593335A1 (en) The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
EP1681280B1 (en) Novel phenol derivatives and antitrypanosoma preventive/therapeutic agent containing the same as active ingredient
KR101560367B1 (ko) 황목련 유래 신규 네오리그난 및 이를 포함하는 뇌세포 보호용 조성물
KR101654977B1 (ko) 키레놀 또는 시게스벡키아 오리엔탈리스 추출물을 포함하는 항비만용 조성물
KR20040058734A (ko) 세포사멸 유도작용을 갖는 후박나무 추출물
US20090110760A1 (en) Lipometabolism improver containing pine bark extract
KR100520496B1 (ko) 세포사멸 유도작용을 갖는 락톤 화합물
AU2012244090B2 (en) Method of producing proanthocyanidin oligomer
NIAZI Choudhary et al.(43) Pub. Date: Feb. 19, 2009
CN101182317A (zh) 含硫原花色素寡聚物的组合物及其制造方法
MX2007010344A (es) Metodo de produccion del oligomero de la proantocianidina.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070824

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070824

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110111

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110405

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110711

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110913

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111012

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141021

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees